These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 35763298)

  • 1. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
    Rybak A; Levy C; Angoulvant F; Auvrignon A; Gembara P; Danis K; Vaux S; Levy-Bruhl D; van der Werf S; Béchet S; Bonacorsi S; Assad Z; Lazzati A; Michel M; Kaguelidou F; Faye A; Cohen R; Varon E; Ouldali N
    JAMA Netw Open; 2022 Jun; 5(6):e2218959. PubMed ID: 35763298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam.
    Nation ML; Manna S; Tran HP; Nguyen CD; Vy LTT; Uyen DY; Phuong TL; Dai VTT; Ortika BD; Wee-Hee AC; Beissbarth J; Hinds J; Bright K; Smith-Vaughan H; Nguyen TV; Mulholland K; Temple B; Satzke C
    Microbiol Spectr; 2023 Feb; 11(1):e0361522. PubMed ID: 36645282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COVID-19 pandemic as an opportunity for unravelling the causative association between respiratory viruses and pneumococcus-associated disease in young children: a prospective study.
    Dagan R; van der Beek BA; Ben-Shimol S; Greenberg D; Shemer-Avni Y; Weinberger DM; Danino D
    EBioMedicine; 2023 Apr; 90():104493. PubMed ID: 36857965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis.
    Ouldali N; Deceuninck G; Lefebvre B; Gilca R; Quach C; Brousseau N; Tapiero B; De Wals P
    Lancet Reg Health Am; 2023 Mar; 19():100448. PubMed ID: 36852331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.
    Hernández S; Muñoz-Almagro C; Ciruela P; Soldevila N; Izquierdo C; Codina MG; Díaz A; Moraga-Llop F; García-García JJ; Domínguez Á
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
    Danino D; Ben-Shimol S; van der Beek BA; Givon-Lavi N; Avni YS; Greenberg D; Weinberger DM; Dagan R
    Clin Infect Dis; 2022 Aug; 75(1):e1154-e1164. PubMed ID: 34904635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data.
    Chiavenna C; Presanis AM; Charlett A; de Lusignan S; Ladhani S; Pebody RG; De Angelis D
    PLoS Med; 2019 Jun; 16(6):e1002829. PubMed ID: 31246954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and
    Cleary DW; Campling J; Lahuerta M; Hayford K; Southern J; Gessner BD; Lo SW; Bentley SD; Faust SN; Clarke SC
    Microbiol Spectr; 2024 Aug; 12(8):e0022424. PubMed ID: 38990033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020-22) compared with the pre-pandemic period (2015-19) in South Africa: an observational study.
    Izu A; Nunes MC; Solomon F; Baillie V; Serafin N; Verwey C; Moore DP; Laubscher M; Ncube M; Olwagen C; Dangor Z; Madhi SA
    Lancet Infect Dis; 2023 Sep; 23(9):1031-1041. PubMed ID: 37141913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Specific Resurgence in Invasive Pneumococcal Disease Incidence in the COVID-19 Pandemic Era and Its Association With Respiratory Virus and Pneumococcal Carriage Dynamics: A Time-Series Analysis.
    Rybak A; Assad Z; Levy C; Bonarcorsi S; Béchet S; Werner A; Wollner A; Valtuille Z; Kaguelidou F; Angoulvant F; Cohen R; Varon E; Ouldali N
    Clin Infect Dis; 2024 Apr; 78(4):855-859. PubMed ID: 38059538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease.
    Desmet S; Wouters I; Heirstraeten LV; Beutels P; Van Damme P; Malhotra-Kumar S; Maes P; Verhaegen J; Peetermans WE; Lagrou K; Theeten H
    Vaccine; 2021 Jan; 39(2):372-379. PubMed ID: 33308889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021.
    Perniciaro S; van der Linden M; Weinberger DM
    Clin Infect Dis; 2022 Sep; 75(7):1149-1153. PubMed ID: 35136983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    De Wals P; Lefebvre B; Deceuninck G; Longtin J
    Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska.
    Bruce MG; Singleton R; Bulkow L; Rudolph K; Zulz T; Gounder P; Hurlburt D; Bruden D; Hennessy T
    Vaccine; 2015 Sep; 33(38):4813-9. PubMed ID: 26247901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
    Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
    Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
    Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.